1. Home
  2. |Insights
  3. |Congress Hammers TSA Exemption From FAR

Congress Hammers TSA Exemption From FAR

Client Alert | less than 1 min read | 08.20.07

In hearings on August 1 before the House Homeland Security Subcommittee on Management, Investigations, and Oversight, David Bodenheimer testified that the Transportation Security Administration (TSA) should be stripped of its exemptions from the Competition in Contracting Act (CICA) and Federal Acquisition Regulation (FAR) in order to bolster competition, reduce regulatory fragmentation, and open TSA procurements to protests and Contract Disputes Act litigation applicable to other agencies. On the next day, the House introduced a bill that, in conjunction with a pending Senate amendment, would bring TSA back into the acquisition mainstream.

Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights